M&A Advisor’s 2011 Magnus Award for Deal of the Year

Pfizer Inc.’s acquisition of King Pharmaceuticals, for which Cadwalader served as counsel to Pfizer, was nominated for the M&A Advisor’s Magnus Award for Deal of the Year.

CadwaladerSpotlight

February 4 | PLI's CMBS and the Real Estate Lawyer 2019: Lender and Borrower Issues in the Capital Market | New York

Jeffrey Rotblat will discuss "Accumulation/Aggregation/Alternative Exit Strategies" at this event.

Cadwalader's research and intelligence platform provides analysis on changes in U.S. financial regulation. Subscribers receive a daily newsletter interpreting new laws, rules and enforcement actions that impact financial institutions.